Colorectal Cancer
CRC incidence on the rise among younger women, ‘demands heightened attention’
WASHINGTON — A time-trend analysis of colorectal cancer incidence over the past 20 years revealed an overall increase among individuals younger than 45 years, with a “disproportionate increase” among younger women vs. men.
Findings highlight ‘desperate need’ to improve end-of-life cancer treatment
Oncologic treatment of adults with various metastatic or advanced solid tumors may not improve OS and could be detrimental to quality of life, according to findings published in JAMA Oncology.
Follow-up colonoscopy for diverticulitis ‘unlikely to provide benefit’ beyond CRC screening
Most patients undergoing colonoscopy after diverticulitis had low risk for colorectal cancer, except those with complicated diverticulitis, whose risk was nearly four times greater than the screening population, according to research.
AACR report: Despite progress, disparities in cancer incidence, mortality persist
The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.
Exercise program may improve heart function among cancer survivors
Moderate to vigorous aerobic and resistance exercise may improve vascular function among cancer survivors, according to findings presented at American Association for Cancer Research Annual Meeting.
Breast, cervical, colorectal cancer screening low in federally qualified health centers
Federally qualified health centers reported substantially lower breast, cervical and colorectal cancer screenings compared with the general U.S. population, highlighting a gap in screening rates for adults from underrepresented groups.
CRC incidence more than triples among children, teens from 1999 to 2020
Colorectal cancer incidence climbed 500% from 1999 to 2020 among children aged 10 to 14 years and 333% among adolescents aged 15 to 19 years, according to research presented at the Digestive Disease Week media briefing.
Study: Cancer screening rates lower in federally qualified health centers
Screenings for breast, cervical and colorectal cancers were significantly lower in federally qualified health centers compared with the general population, a study in JAMA Internal Medicine showed.
Are new colorectal cancer screening options a match for 'the gold standard'?
New testing options for colorectal cancer will likely expand access to screening, but they are not as reliable as a colonoscopy, according to experts.
FDA approves ColoSense stool RNA test to detect colorectal cancer in average-risk adults
The FDA has approved Geneoscopy Inc.’s ColoSense multitarget stool RNA test for adults aged 45 years or older at average-risk for developing colorectal cancer, according to a company press release.